TerminatedNot Applicable

A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders

Stopped: Discontinued due to a strategic shift in research focus. The steering committee decided to replace the broad registry with multiple targeted prospective cohort studies to ensure higher statistical significance and more focused clinical evidence.

United States908 participantsStarted 2016-01

Plain-language summary

Details regarding the degenerative spine disorders will be collected with a specific focus on the use of osteobiologics in treating degenerative conditions and their impact on fusion, as well as patient-reported outcomes for these conditions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient aged 18 years or older * Patient diagnosed with a degenerative spine disorder who receives treatment for the degenerative spine disorder * Patient capable of understanding the content of the patient information / Informed Consent Form * Patient willing and able to participate in the registry * Patient who has agreed to participate in the registry by providing consent according to the applicable local law and the declaration of Helsinki Exclusion Criteria: * None

What they're measuring

Use of Osteobiologics - Within the registry information on the use of osteobiologis (autografts, allografts, BMA/cells, BMP, DBM, matrices/carriers, platelets) are collected

Timeframe: Every standard of care scheduled follow-up visit up to 3 years

Trial details

NCT IDNCT02802033

SponsorAO Innovation Translation Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Degenerative Diseases, Spinal Cord trials